)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Royalty Pharma
Royalty Pharma (RPRX) investor relations material
Royalty Pharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary10 Apr, 2026
Executive summary
Annual General Meeting scheduled for June 4, 2026, in New York, with voting available online or in person.
Shareholders are encouraged to review proxy materials and annual reports before voting.
Voting matters and shareholder proposals
Election of nine directors, with all nominees recommended for approval.
Advisory vote on executive compensation and approval of the U.K. directors' remuneration report.
Ratification of Ernst & Young LLP as independent registered public accounting firm and re-appointment as U.K. statutory auditor.
Approval of U.K. audited annual report and accounts for the fiscal year ended December 31, 2025.
Authorization for the Board to allot shares, determine auditor remuneration, and purchase Class A ordinary shares.
Special resolution to authorize the Board to allot shares without rights of pre-emption.
Board of directors and corporate governance
Nine director nominees listed, including individuals with medical, financial, and leadership backgrounds.
Board recommends voting in favor of all director nominees.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Royalty Pharma
- Double-digit growth, record capital deployment, and robust 2026 outlook highlight strong momentum.RPRX
Q4 202513 Apr 2026 - Market leader in biopharma royalties, delivering robust growth and superior returns through scale and innovation.RPRXCorporate presentation13 Apr 2026
- Board recommends all proposals as company posts strong growth, robust governance, and ESG progress.RPRXProxy filing10 Apr 2026
- Strategic expansion, major deals, and disciplined growth drive strong returns and future outlook.RPRXTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Highlighted robust diligence, portfolio growth, and a $3B buyback after management internalization.RPRXRBC Capital Markets Global Healthcare Conference 20253 Feb 2026
- Double-digit growth, raised 2024 guidance, and $2B+ deployed in new royalty investments.RPRXQ2 20242 Feb 2026
- Recent high-value deals in MS and glioma highlight a resilient, opportunity-driven strategy.RPRXGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Strong deal flow, structural advantages, and repeat partnerships drive predictable growth.RPRXMorgan Stanley’s 22nd Annual Global Healthcare Conference22 Jan 2026
- Q3 2024 saw 15% growth, $544M net income, raised guidance, and robust capital deployment.RPRXQ3 202416 Jan 2026
Next Royalty Pharma earnings date
Q1 20266 May, 2026
Royalty Pharma
Next Royalty Pharma earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage